KCM
BSX icon

Kanawha Capital Management’s Boston Scientific BSX Stock Holding History

Kanawha Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,081
Closed -$210K – 215
2025
Q1 		$210K Buy
+2,081
New +$210K 0.02% 210

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kanawha Capital Management's BSX Position: Q2 2025 in Review

Kanawha Capital Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 2,081 shares — an estimated $210K sold.

Kanawha Capital Management first reported a position in BSX in Q1 2025 and held it in 1 quarter. The position peaked at $210K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Kanawha Capital Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Kanawha Capital Management sold 2,081 Boston Scientific shares in Q2 2025, an estimated $210K.
  • Kanawha Capital Management first reported a position in Boston Scientific in Q1 2025 and held it in 1 quarter.
  • Kanawha Capital Management's Boston Scientific position peaked at $210K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Kanawha Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.